Equity

Share Repurchase Authorization Limit

Viatris Share Repurchase Authorization Limit increased by 100.0% to $2.00B in Q1 2024 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ4 2016
Last reportedQ4 2024

How to read this metric

Higher limits suggest strong cash flow and management's belief that the stock is undervalued.

Detailed definition

This is the maximum dollar value or share count authorized by the Board of Directors for the repurchase of the company's...

Peer comparison

Common among mature, cash-generative companies seeking to optimize their capital structure.

Metric ID: share_repurchase_authorization_limit

Historical Data

2 periods
 Q1 '22Q1 '24
Value$1.00B$2.00B
QoQ Change—+100.0%
Range$1.00B – $2.00B

Share Repurchase Authorization Limit at Other Companies

McKesson logo
McKessonMCKView metric
West Pharmaceutical Services logo
West Pharmaceutical ServicesWSTView metric
Royalty Pharma logo
Royalty PharmaRPRXView metric

Frequently Asked Questions

What is Viatris's share repurchase authorization limit?
Viatris (VTRS) reported share repurchase authorization limit of $2.00B in Q1 2024.
What does share repurchase authorization limit mean?
The maximum amount the company is allowed to spend on buying back its own stock.